세계의 면역침강 시장(2024-2028년)

The immunoprecipitation market is forecasted to grow by USD 270.1 mn during 2023-2028, accelerating at a CAGR of 6.01% during the forecast period. The report on the immunoprecipitation market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing r and d in biopharmaceuticals, rising demand for therapeutic antibodies, and growing focus on newborn screening tests.

Technavio's immunoprecipitation market is segmented as below:

By End-user

• Academic and research institutes
• Contract research organizations
• Pharmaceutical and biotechnology companies

By Type

• Chromatin immunoprecipitation
• Individual protein immunoprecipitation
• Co-immunoprecipitation
• RNA immunoprecipitation

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the rising number of genome projects as one of the prime reasons driving the immunoprecipitation market growth during the next few years. Also, increasing clinical trials and growing expansion of contract manufacturing organizations and cros will lead to sizable demand in the market.

The report on the immunoprecipitation market covers the following areas:

• Immunoprecipitation market sizing
• Immunoprecipitation market forecast
• Immunoprecipitation market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading immunoprecipitation market vendors that include Active Motif Inc., Agilent Technologies Inc., Becton Dickinson and Company, Bio Rad Laboratories Inc., Cell Signaling Technology Inc., Chargen Life Sciences LLP, CLOUD CLONE CORP., Creative Biolabs, Danaher Corp., GenScript Biotech Corp., JSR Micro Inc., Merck KGaA, OriGene Technologies Inc., PerkinElmer Inc, Proteintech Group Inc., Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., Sino Biological Inc., and Thermo Fisher Scientific Inc.. Also, the immunoprecipitation market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview

2 Market Landscape

• 2.1 Market ecosystem

3 Market Sizing

• 3.1 Market definition
• 3.2 Market segment analysis
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

• 4.1 Global immunoprecipitation market 2018 - 2022
• 4.2 End-User Segment Analysis 2018 - 2022
• 4.3 Type Segment Analysis 2018 - 2022
• 4.4 Geography Segment Analysis 2018 - 2022
• 4.5 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

• 5.1 Five forces summary
• 5.2 Bargaining power of buyers
• 5.3 Bargaining power of suppliers
• 5.4 Threat of new entrants
• 5.5 Threat of substitutes
• 5.6 Threat of rivalry
• 5.7 Market condition

6 Market Segmentation by End-user

• 6.1 Market segments
• 6.2 Comparison by End-user
• 6.3 Academic and research institutes - Market size and forecast 2023-2028
• 6.4 Contract research organizations - Market size and forecast 2023-2028
• 6.5 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028
• 6.6 Market opportunity by End-user

7 Market Segmentation by Type

• 7.1 Market segments
• 7.2 Comparison by Type
• 7.3 Chromatin immunoprecipitation - Market size and forecast 2023-2028
• 7.4 Individual protein immunoprecipitation - Market size and forecast 2023-2028
• 7.5 Co-immunoprecipitation - Market size and forecast 2023-2028
• 7.6 RNA immunoprecipitation - Market size and forecast 2023-2028
• 7.7 Market opportunity by Type

8 Customer Landscape

• 8.1 Customer landscape overview

9 Geographic Landscape

• 9.1 Geographic segmentation
• 9.2 Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• 9.4 Europe - Market size and forecast 2023-2028
• 9.5 Asia - Market size and forecast 2023-2028
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• 9.7 US - Market size and forecast 2023-2028
• 9.8 UK - Market size and forecast 2023-2028
• 9.9 China - Market size and forecast 2023-2028
• 9.10 Germany - Market size and forecast 2023-2028
• 9.11 Canada - Market size and forecast 2023-2028
• 9.12 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• 11.3 Landscape disruption
• 11.4 Industry risks

12 Vendor Analysis

• 12.1 Vendors covered
• 12.2 Market positioning of vendors
• 12.3 Active Motif Inc.
• 12.4 Agilent Technologies Inc.
• 12.5 Becton Dickinson and Company
• 12.6 Bio Rad Laboratories Inc.
• 12.7 Cell Signaling Technology Inc.
• 12.8 Danaher Corp.
• 12.9 GenScript Biotech Corp.
• 12.10 JSR Micro Inc.
• 12.11 Merck KGaA
• 12.12 OriGene Technologies Inc.
• 12.13 PerkinElmer Inc
• 12.14 Proteintech Group Inc.
• 12.15 Rockland Immunochemicals Inc.
• 12.16 Santa Cruz Biotechnology Inc.
• 12.17 Thermo Fisher Scientific Inc.

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• 13.3 Currency conversion rates for US$
• 13.4 Research methodology
• 13.5 List of abbreviations